Diabetic Neuropathy
Symptoms, Doctors, Treatments, Advances & More

Diabetic Neuropathy Overview

Save information for later
Sign Up

Learn About Diabetic Neuropathy

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Diabetic Neuropathy Local Doctors?
Distinguished in Diabetic Neuropathy
Endocrinology
Distinguished in Diabetic Neuropathy
Endocrinology

Ballad Health Medical Associates Diabetes And Endocrinology Center

16000 Johnston Memorial Drive, Suite 112, 
Abingdon, VA 
Languages Spoken:
English

Matthew Beasey is an Endocrinologist practicing medicine in Abingdon, Virginia. Dr. Beasey is rated as a Distinguished provider by MediFind in the treatment of Diabetic Neuropathy. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Neuropathy, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D). Dr. Beasey is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

Distinguished in Diabetic Neuropathy
Family Medicine
Distinguished in Diabetic Neuropathy
Family Medicine

OSF Medical Group - Primary Care

1701 East College Avenue Floor 1, 
Bloomington, IL 
Languages Spoken:
English
Offers Telehealth

Gustavo Galue is a primary care provider, practicing in Family Medicine in Bloomington, Illinois. Dr. Galue is rated as a Distinguished provider by MediFind in the treatment of Diabetic Neuropathy. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Xanthoma, High Cholesterol, Familial Combined Hyperlipidemia, and Cirrhosis. Dr. Galue is board certified in American Board Of Family Medicine.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Diabetic Neuropathy
Neurology | Neuroradiology
Elite in Diabetic Neuropathy
Neurology | Neuroradiology

Taubman Center

1500 E Medical Center Dr, Floor 1 Reception C, 
Ann Arbor, MI 
Languages Spoken:
English
Offers Telehealth

Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine.

What are the latest Diabetic Neuropathy Clinical Trials?
Investigation of the Effects of Glycemic Control and Clinical Parameters on Tibial Nerve Conduction Latency in Individuals With Diabetic Peripheral Neuropathy

Summary: This observational cross-sectional study aims to investigate the effects of glycemic control and clinical parameters on tibial nerve conduction latency in individuals with diabetic peripheral neuropathy. Adults aged 45 to 76 years with diabetic peripheral neuropathy will be evaluated at a neurology and clinical neurophysiology clinic. Data collection will include demographic and clinical character...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy

Summary: The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic peripheral neuropathy (DPN).